Invus Global Management, LLC — SEC Form 4 filings

SEC reporting owner CIK 2005369. 8 Form 4 filings on record with FilingPulse; latest filed 2026-02-06.

Transaction summary — filings shown

Covers all 8 filings on record, filed 2024-07-30 to 2026-02-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Scholar Rock Holding Corp (SRRK)10% owner36 legs · 2,009,433 sh · $82,397,6392
LEXICON PHARMACEUTICALS, INC. (LXRX)Director, 10% owner11 leg · 1,538,462 sh · $2,000,0013
GLYCOMIMETICS INC (GLYC)10% owner49 legs · 2,271,499 sh · $488,749

Form 4 filings — Invus Global Management, LLC

FiledFormIssuerReported transactionsSource
2026-02-064Scholar Rock Holding Corp (SRRK)
jointly with Siren, L.L.C., DEBBANE RAYMOND
Option exercise/expiry (X): 1,575,008 @ $7.35 · Option exercise/expiry (X): 1,575,008 (derivative) @ $0EDGAR
2026-02-044LEXICON PHARMACEUTICALS, INC. (LXRX)
jointly with Siren, L.L.C., DEBBANE RAYMOND, Artal Participations S.a r.l., Artal International S.C.A., Artal International Management S.A., Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend
Grant/award (A): 18,553,846 @ $1.30 · Grant/award (A): 3,846,154 @ $1.30 · Purchase (P): 1,538,462 @ $1.30 · Grant/award (A): 367,145.12 @ $65EDGAR
2024-12-124Scholar Rock Holding Corp (SRRK)
jointly with Invus Public Equities, L.P., Invus Public Equities Advisors, LLC, Siren, L.L.C., DEBBANE RAYMOND
Sale (S): 1,600,000 @ $41.65EDGAR
2024-11-274Scholar Rock Holding Corp (SRRK)
jointly with Invus Public Equities, L.P., Invus Public Equities Advisors, LLC, Siren, L.L.C., DEBBANE RAYMOND
Sale (S): 208,272 @ $37.63 · Sale (S): 43,887 @ $38.43 · Sale (S): 126,442 @ $39.51 · Sale (S): 30,683 @ $40.14 · Sale (S): 149 @ $40.98EDGAR
2024-08-094GLYCOMIMETICS INC (GLYC)
jointly with Invus Public Equities, L.P., Invus Public Equities Advisors, LLC, Siren, L.L.C., DEBBANE RAYMOND
Sale (S): 61,488 @ $0.18 · Sale (S): 260,873 @ $0.19EDGAR
2024-08-074GLYCOMIMETICS INC (GLYC)
jointly with Invus Public Equities, L.P., Invus Public Equities Advisors, LLC, Siren, L.L.C., DEBBANE RAYMOND
Sale (S): 164,523 @ $0.19 · Sale (S): 55,732 @ $0.18EDGAR
2024-08-054GLYCOMIMETICS INC (GLYC)
jointly with Invus Public Equities, L.P., Invus Public Equities Advisors, LLC, Siren, L.L.C., DEBBANE RAYMOND
Sale (S): 63,564 @ $0.22 · Sale (S): 286,200 @ $0.20EDGAR
2024-07-304GLYCOMIMETICS INC (GLYC)
jointly with Invus Public Equities, L.P., Invus Public Equities Advisors, LLC, Siren, L.L.C., DEBBANE RAYMOND
Sale (S): 258,335 @ $0.24 · Sale (S): 363,949 @ $0.24 · Sale (S): 756,835 @ $0.22EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2005369 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →